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Abstract The objective of this historical cohort study is to
identify if there are differences in soft tissue reactions and
skin thickening between implantation of the percutaneous
bone-anchored hearing implant (BAHI) using the der-
matome or linear incision technique. All adult patients who
received a BAHI between August 2005 and January 2013
were selected. One surgeon performed all procedures and
only the dermatome and linear incision technique were
used. A total of 132 patients/implants were included and
significantly more patients with risk factors were seen in
the linear incision cohort. A soft tissue reaction Hol-
gers C1 was present in 18 patients (40.9 %) in the der-
matome compared to 36 patients (40.9 %) in the linear
incision group. A Holgers C2 was noticed in 9 (20.5 %)
and 19 (21.6 %) patients, respectively. Skin thickening was
described in 14 (31.8 %) and 11 patients (12.5 %) in,
respectively, the dermatome and linear incision cohort,
which was a significant difference (p = 0.001). Neverthe-
less, therapeutic interventions were effective. In conclu-
sion, there was no significant difference in (adverse) soft
tissue reactions; however, skin thickening was more pre-
sent in the dermatome technique. In addition, significantly
more patients with risk factors were allocated to the linear
incision technique. Based on these results, the linear inci-
sion is advocated as preferred technique.
Keywords Baha  Bone-anchored hearing implant 
Surgical technique  Linear incision  Dermatome
technique  Soft tissue reactions
Introduction
Since the first implantation in 1977 by Tjellstro¨m, percu-
taneous bone-anchored hearing implants (BAHIs) offer an
appealing solution in hearing rehabilitation for patients
with a conductive or mixed hearing loss [1, 2] and single-
sided deafness [3–6]. These devices stimulate the cochlea
directly through the principle of bone conduction [1]. The
ongoing developments in the field of bone conduction
devices have led to a safe procedure of implantation with a
lack of major complications [7]. However, depending on
type of implant and abutment, surgical technique and
postoperative care, soft tissue reactions are still occasion-
ally a problem [7–12]. The Holgers’ classification is most
commonly used to grade these soft tissue reactions [12].
The surgical procedure for implantation in adults is
nowadays performed as a one-staged procedure [2]. Vari-
ous surgical techniques have been developed, which started
with the free retroauricular full-thickness skin graft [13]
and later the pedicled grafts [14]. Over the years, the der-
matome and linear incision technique have been introduced
with the goal to further minimize skin problems postop-
eratively [15, 16]. The dermatome technique was devel-
oped to standardize the pedicled flap technique and create a
thinner skin graft. A Baha dermatome is used to create a
skin graft without hair follicles, which stays attached to the
skin on one side. The soft tissue beneath will be removed,
with the creation of a gradual slope down to the implant
site. The periosteum remains intact with exception of the
place of insertion of the implant [17, 18]. In the linear
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incision technique, a longitudinal incision of about 30 mm
posterosuperiorly to the ear canal is made. The periosteum
is exposed and mobilized after sharp dissection of the
subcutaneous tissue. Subsequently, the implant is placed
and subcutaneous tissue will be resected over an area of
approximately 2 cm around the incision. In addition, the
remaining periosteum is removed [19]. Recent studies
show promising results in the context of surgical tech-
niques with tissue preservation [20–23].
Based on the available literature, studies reporting about
the dermatome technique show an overall higher rate of
skin problems compared to studies regarding the linear
incision technique and nowadays this latter technique is
gaining more interest as standard of care. Nevertheless,
variability in setup, follow-up and surgical techniques
among these studies may influence the rate of skin com-
plications [16]. To our knowledge, there are only two
comparative studies that evaluate major postoperative
complications between these two techniques: one as part of
a comparison of several techniques [24] and another with a
limited follow-up without using the Holgers classification
[25]. The aim of the current historical cohort study is to
provide more rigorous support of the superiority of the
linear incision technique by directly comparing both the
dermatome and linear incision technique with subcuta-
neous soft tissue reduction in adults. There will be an
evaluation if there are differences in the presence of soft
tissue reactions, as classified by the Holgers grading sys-
tem, and skin thickening between these two techniques,
alternatively performed by a single surgeon in a general,
teaching hospital.
Materials and methods
Patients
All adult patients (aged 18 years or older) who received
any type of percutaneous bone-anchored hearing implant
(BAHI) at one large Dutch general, teaching hospital
between August 2005 and January 2013 were consecu-
tively selected from our local Bone Implant database.
Indications for a percutaneous BAHI were conductive or
mixed hearing loss and single-sided deafness. Eligibility
criteria were: one-staged procedure, primary placement of
the implant (no previous implant removal or loss) and
availability of the patient’s medical chart including at least
one postoperative visit at the outpatient clinic.
Surgical techniques and post-surgery protocol
Only the dermatome technique [17] and simplified linear
incision technique with subcutaneous soft tissue reduction
[19] were used in the selected study period. In addition, all
patients were operated on by the same surgeon (S.B.).
There was preoperatively screening for an increased risk of
skin flap necrosis [17]. If one or more possible risk factors
were present or suspected, patients were operated with the
linear incision technique. Otherwise a patient underwent
generally the procedure using the dermatome technique.
Risk factors were high age (75 years or older), smoking,
diabetes mellitus, mental retardation or cardiovascular
comorbidity [26–29].
The first postoperative visit was 1 week after surgery,
when the healing cap and gauze with antibiotic ointment
(only in the 41 first patients) or Mepilex foam (Mo¨lyn-
lycke Health Care, Gothenburg, Sweden; in the majority
of patients) were removed. The wound was inspected and
all patients received, conform protocol in the hospital,
topical therapy with fusidic acid for 2–4 weeks. Further
follow-up was after 3 weeks, 6 months and 12 months
and then in principle every year. Extra appointments were
arranged by patients or physicians if problems arose or
depending on individual needs. During each visit, there
was registration of the degree of soft tissue reaction and
skin thickening. If any postoperative problems occurred,
i.e. skin flap necrosis, wound dehiscence or implant loss,
this was also recorded. Besides, there was registration of
therapeutic interventions, if applicable. End of the follow-
up was defined as the last follow-up before November
2015.
Case analysis
All data were obtained from the local database and
patient’s medical records of the aforementioned teaching
hospital. The operative report was used to collect infor-
mation about the surgical technique and implant type.
Furthermore, the notes from the physical examination in all
follow-up contacts by one of the physicians or residents
were used to determine the presence of postoperative
complications, skin thickening and soft tissue reactions.
The postoperative complications were divided into skin
flap necrosis, wound dehiscence or implant loss. Skin flap
necrosis was further split in minor, medium or major,
which indicated, respectively, a non-vital skin flap of less
than 25, 25–50 % or more than 50 % of the total flap [17].
Wound dehiscence was subdivided into dehiscence without
need for surgical intervention versus dehiscence which
required a free skin graft. Finally, in case of implant loss
there was registration of the cause.
The skin was described as low or thickened. The term
skin thickening was defined as (partially) high skin around
the abutment or soft tissue overgrowth. The possible ther-
apeutic intervention was corticosteroid injection with tri-
amcinolone acetonide, otherwise an extended abutment
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could be placed or eventually surgical soft tissue revision
might be considered.
The soft tissue reactions were graded according to the
Holgers classification [12]. A distinction was made
between soft tissue reactions in general and adverse soft
tissue reactions, because of the clinical implications of the
latter (i.e. indication for (topical) treatment). An adverse
soft tissue reaction was defined as a Holgers 2 or higher
and a soft tissue reaction as a Holgers 1 or higher. Besides,
if the Holgers notation was missing but there was notation
of redness, swelling, moistness and/or granulation, this was
interpreted as the presence of a soft tissue reaction. No
notation of signs of inflammation in the physical exami-
nation was considered as a Holgers grade 0, i.e. the absence
of soft tissue reaction.
Finally, the background characteristics gender, body
mass index, diabetes mellitus, mental retardation, smoking
and cardiovascular comorbidity were registered, following
recent studies focusing on identification of these comor-
bidities as (potential) risk factor for soft tissue reactions or
implant loss [8, 30–34]. In addition, some characteristics
may be associated with skin flap necrosis or impaired
wound healing [26–28].
Statistical analysis
A comparison of background characteristics was performed
using a Student’s t test if there was a normal distribution;
otherwise, a Mann–Whitney U test was performed. The
Kolmogorov–Smirnov test was used to determine whether
the criteria for normal distribution were met. Chi-square
test was performed if the outcome was a proportion.
In the context of the presence of skin thickening and
(adverse) soft tissue reactions, there were survival curves
calculated using the Kaplan–Meier method. The log-rank
test was executed to identify differences between these
curves. The level of significance applied was p = 0.05. All
our analyses were performed using Statistical Package for
Social Sciences (IBM SPSS Statistics for Windows,
Armonk, NY; IBM Corp), version 22.0.
Results
Patients
In the period from August 2005 until January 2013, a total
of 146 implants were placed. A cohort of 132 implants met
the eligibility criteria, because 14 implants were excluded:
10 implants were placed in children (aged younger than
18 years) and 4 implants had no initial placement. Since
none of these implants were placed bilaterally, the cohort
consisted also of 132 patients. A total of 44 patients were
operated using the dermatome technique with a mean age
of 50.3 years (range 26–72, SD ±12.3) and median follow-
up of 40.5 months (interquartile range (IQR) 22.5–72.25).
The linear incision group consisted of 88 patients with a
mean age of 59.3 years (range 22–89, SD ±14.3) and
median follow-up of 56.5 months (IQR 29.5–89.75).
All the baseline patient characteristics are summarized in
Table 1.Asmentioned, patientswere preoperatively screened
for an increased risk of skin flap necrosis and underwent in
general the linear incision technique if one or more possible
risk factors were present. This explains the significant dif-
ference found in age (p = 0.001), diabetes mellitus
(p = 0.039), cardiovascular comorbidity (p = 0.036) and
smoking (p = 0.031) between the groups. Table 2 shows the
surgical characteristics. In addition, only 5.5 and 6.0 mm (and
no extended) abutments were used for previous generation
Cochlear, respectively, all other implants. Moreover, signif-
icantly more previous generation implants were placed in the
linear incision cohort (p = 0.033).
Postoperative complications
Skin flap necrosis was noticed only in the dermatome
technique. Minor skin flap necrosis was seen in three
patients (6.8 %) and medium skin flap necrosis in one
patient (2.3 %). None of these cases required surgical
intervention. In addition, no patient developed major skin
flap necrosis. Dehiscence of the surgical wound was only
seen in the linear incision technique. In 26 patients, reg-
istration of dehiscence was without need of surgical
intervention (29.5 %) and in two patients the severity
required a free skin graft (2.3 %). One of these patients had
multiple risk factors for impaired wound healing; the other
patient had postoperative persistent blood clots in the
wound because of dysregulated coagulation (which
impaired closure of the dehiscence).
During complete follow-up, four implants were lost
which were all previous generation implants (Cochlear
flange fixture, 4 mm) and placed according to the linear
incision technique. All of these implants were lost after
more than 6 years of follow-up (74, 78, 84 and 89 months).
Two implants were lost spontaneously after a distinct
period with pain, one implant was lost presumptively after
a peri-implantitis and one implant was lost due to trauma.
No implant was lost because of a Holgers grade 4.
Skin thickening
The presence of skin thickening was described in 14
patients (31.8 %) in the dermatome group and 11 patients
(12.5 %) in the group which were operated using the linear
incision technique. Nevertheless, soft tissue overgrowth
was not recorded during the entire follow-up. The Kaplan–
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Meier curves are shown in Fig. 1. These curves are
showing the probability of surviving, i.e. not encountering
the condition of skin thickening, in a given length of time
for patients in the different cohorts. The presence of skin
thickening was significantly higher in the dermatome
cohort (p = 0.001). In addition, Table 3 shows the
therapeutic interventions in patients with skin thickening.
No intervention was necessary in three patients. All other
patients received triamcinolone acetonide injection and/or
a higher abutment. Soft tissue reduction was performed in
two patients. The therapeutic interventions were eventually
effective in all cases.
Table 1 Summary of the
patient characteristics
Dermatome Linear incision P values
n % n %
Total patients/implants 44 100 88 100
Gender
Male 20 45.5 53 60.2 0.108
Female 24 54.5 35 39.8
Age at surgery
Mean (years) [±SD] 50.3 [12.3] 59.3 [14.3] 0.001*
Range (years) 26–72 22–89
Aetiology of hearing loss
Conductive/mixed hearing loss 34 77.3 83 94.3
Single-sided deafness 10 22.7 5 5.7
Comorbidity factor
Mean body mass index (kg/m2) [±SD] 26.9 [4.4] 27.1 [4.4] 0.816
Diabetes mellitus 1 2.3 12 13.6 0.039*
Cardiovascular comorbidity 18 40.9 53 60.2 0.036*
Mental retardation 0 0 5 5.7 0.107
Smoking 4 9.1 21 23.9 0.031*
* Significant difference (p\ 0.05)
Table 2 Summary of the
surgical characteristics
Characteristics Dermatome Linear incision
n % n %
Follow-up
Median (months) 40.5 56.5
Interquartile range (months) 22.5–72.25 29.5–89.75
Side
Right 23 52.3 46 52.3
Left 21 47.7 42 47.7
Implant length
3 mm Cochlear 0 0 5 5.7
4 mm Cochlear 36 81.8 71 80.7
3 mm Oticon 0 0 1 1.1
4 mm Oticon 8 18.2 11 12.5
Implant type
Previous generation Cochlear (‘‘flange fixture’’) 25 56.8 66 75
BIA300 11 25 10 11.4
Ponto regular 8 18.2 12 13.6
Bottom
Bone 33 75.0 63 71.6
Dura 8 18.2 19 21.6
Bone/dura 3 6.8 6 6.8
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Soft tissue reactions
In the group of patients operated with the dermatome
technique, a soft tissue reaction (i.e. Holgers C1) was
noticed in 18 persons (40.9 %) compared to 36 persons
(40.9 %) in the group of the linear incision technique.
Adverse soft tissue reactions (i.e. Holgers C2) were noticed
in 9 patients (20.5 %) who underwent the procedure with
the dermatome. In comparison, 19 patients (21.6 %) in the
group of the linear incision technique encountered an
adverse soft tissue reaction. For these two outcomes
measures, the Kaplan–Meier method was used to calculate
survival curves (Figs. 2, 3). No significant differences were
found between the dermatome and linear incision technique
for the presence of both soft tissue reactions (p = 0.710)
and adverse soft tissue reactions (p = 0.925).
Due to the aforementioned significantly higher rate of
previous generation implants in the linear incision group, a
statistical subanalysis was performed for the soft tissue
reactions and skin thickening according to implant type
(i.e. previous generation bone implants (‘‘flange fixture’’)
versus the more recent BIA300 and Ponto Regular
implants). The percentage of implants encountering skin
thickening, Holgers C1 and Holgers C2 was, respectively,
24.2, 48.4 and 28.6 % in the previous generation bone
implant group. In the group of BIA300 and Ponto Regular
implants these percentages were, respectively, 7.3, 24.4
and 4.9 %. A Kaplan–Meier analysis with log-rank test
revealed that the difference in skin thickening (p = 0.119)
and soft tissue reactions Holgers C1 (p = 0.120) was not
significant. Nevertheless, significantly more adverse soft
tissue reactions Holgers C2 were encountered in the pre-
vious generation implants (p = 0.020).
A subanalysis of patients without any possible risk
factors for skin problems could not be performed due to a
too low number of eligible patients in both cohorts for
comparison.
Discussion
In this retrospective cohort study, 132 implants were
studied in 132 patients with a total median follow-up time
of 47.5 months (IQR 26.0–84.75). There were no
Fig. 1 The Kaplan–Meier analysis for skin thickening (p = 0.001)
Table 3 Overview of the
different therapeutic
interventions for skin thickening
and how often these procedures
had to be performed in every
patient
Dermatome Linear incision
n % n %
Number of patients with skin thickening 14 100 11 100
Number of triamcinolone acetonide injections
0 1 7.1 3 27.3
1–2 5 35.7 5 45.5
3–5 3 21.4 2 18.2
6–10 5 35.7 1 9.1
Number of abutment changes
0 8 57.1 8 72.7
1 6 42.9 1 9.1
2 0 0 2 18.2
Number of soft tissue reductions
0 13 92.9 10 90.9
1 1 7.1 0 0
2 0 0 1 9.1
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statistically significant differences found in the presence of
soft tissue reactions or adverse soft tissue reactions
between patients who underwent surgery with the der-
matome technique and patients operated with the linear
incision technique in the current set up. Skin thickening
was significantly more encountered in the dermatome
cohort, but could be treated successfully.
Over the last decade, several developments and
improvements have been made in implant types, sound
processors and surgical techniques. In the field of the latter,
both the dermatome and linear incision technique became
popular in many centres. However, studies regarding the
dermatome technique reported an overall higher rate of
skin problems [35–37] compared to the linear incision
technique [8, 19], although methodological variability
could influence these outcomes and impair adequate com-
parison [16]. The linear incision technique is more and
more used as the preferred technique in many clinics.
Moreover, several promising modifications in this surgical
approach are investigated in the current literature, for
example the use of minimally invasive techniques without
subcutaneous tissue thinning [20–23]. Unfortunately, some
of these studies use the dermatome technique as control
cohort [20, 21]. Nevertheless, to our knowledge, this is the
first large-scale historical cohort study that actually directly
compares patients operated with the dermatome and the
linear incision technique with soft tissue reduction in the
context of skin problems using the Holgers grading system
consequently. It will contribute to more solid support of the
linear incision technique as preferred surgical technique in
the bone-anchored hearing implant surgery.
Furthermore, this study reveals a relatively long follow-
up with a median of almost 4 years. The presence of skin
problems is concentrated in the first years postoperatively,
thus in most implants this period is covered. In addition,
only four (2.9 %) of all identified implants in adults placed
during the study period had to be excluded. The combi-
nation of this very low exclusion rate and a presence of
(adverse) soft tissue reaction that is comparable with other
studies, though for dermatome technique somewhat lower,
[16] suggests a representative sample.
Moreover, both surgical techniques were performed by
the same surgeon, so differences in other aspects of the
surgical and perioperative approaches could be minimized
to prevent possible confounding. In addition, this surgeon
himself saw in general all patients during their complete
follow-up. Regarding the subjective interpretation of most
of the outcome measures, this small variability in observers
is rather advantageous.
Nevertheless, the allocation of patients was not ran-
domized. As stated, patients with one or more (suspected)
risk factors for skin problems underwent implantation with
the linear incision technique in most cases. Therefore,
significantly more patients with risk factors (i.e. higher age,
diabetes mellitus, cardiovascular disease and smoking)
were seen in that cohort. This selection bias may have led
to an underestimation of the skin problems in the der-
matome cohort and overestimation in the linear incision
Fig. 2 The Kaplan–Meier analysis for soft tissue reaction Hol-
gers C1 (p = 0.710)
Fig. 3 The Kaplan–Meier analysis for adverse soft tissue reaction
Holgers C2 (p = 0.925)
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group. Hence, there could have been a difference in (ad-
verse) soft tissue reaction if there would have been a more
equal distribution.
In addition, 91 of 132 included implants (68.9 %) were
previous generation implants from Cochlear (‘‘flange fix-
ture’’). This is a limitation of the study, because ongoing
advances in implants and abutments have led to less skin
reactions in the current types [38], with most recently, for
example, the introduction and investigation of abutments
with a hydroxyapatite coating [39, 40]. Our local Bone
Implant database revealed that adverse soft tissue reactions
Holgers C2 were significantly more encountered in the
cohort with previous generation implants (‘‘flange fixture’’)
compared to the newer implant abutments, i.e. Ponto Reg-
ular and BIA300. Although not significant, there was
clearly a trend of less soft tissue reactions Holgers C1 and
skin thickening in patients with these newer implants. The
significantly higher rate of previous generation implants in
the linear incision cohort contributes to the presumption that
skin problems would have been noticed less frequently in
this group, if the rate of current implant types was compa-
rable with the dermatome group. Consequently, there may
have been a difference in (adverse) soft tissue reaction and
an even greater difference in presence of skin thickening.
An additional point of discussion is the missing of
Holgers classification in, however, a substantial minority,
of the follow-up contacts. In these cases, only a description
of the skin surrounding the titanium skin-penetrating
abutment was available and, as comprehensively described
in Materials and Methods, assumptions were made about
the presence or absence of a soft tissue reaction. Moreover,
there does not exist a uniform grading system of skin
thickening in the international literature yet. Nevertheless,
as compared to other studies, the grade of skin thickening
noticed was relatively mild. There was no overgrowth of
skin reported and revision surgery was performed in only 2
patients (one from each group) [8, 11, 16, 35, 36].
As to speculate on possible causes for the higher rate of
skin thickening following the dermatome technique, two
factors might be of interest. First, the periost is preserved in
the dermatome technique whereas removed in the linear
incision approach, which might result in different mobility
of the skin surrounding the abutment. Second, although
both techniques make use of subcutaneous soft tissue
reduction, the technical performance of this reduction (i.e.
manually or mechanically) might be of influence in post-
operative outcomes. In other words, skin reduction in the
linear incision technique is less invasive and for that reason
causes less traumatized skin, which would result in a lower
percentage of patients with skin thickening.
In conclusion, no significant difference was found in the
presence of soft tissue reactions and adverse soft tissue
reactions (i.e. Holgers grade 2 or higher) between the
dermatome and linear incision technique. However, the
allocation of significantly more patients with risk factors
and patients with previous generation implants to the linear
incision cohort may have caused an underestimation of the
difference between these two techniques. Skin thickening
was significantly more seen in patients operated with the
dermatome technique, which was treated successfully in all
cases. Although items like aesthetic appearance, numbness,
surgery time and healing time are not addressed in the
current study, the linear incision technique should be pre-
ferred over the dermatome technique, based on the com-
bination of no difference or possibly more (adverse) soft
tissue reactions in the dermatome cohort and a significantly
higher rate of skin thickening in this group.
As a matter of fact, this is the first historical cohort study
directly comparing two widely used surgical techniques for
BAHI implantation in such a large group of patients with a
long-term follow-up. It adds knowledge for clinical prac-
tice and research and also contributes as a useful reference
work. This study shows the strength of the linear incision in
minimizing postoperative skin problems. Such well-foun-
ded evidence is of great importance, especially in the
dynamic field of ongoing developments in bone-anchored
hearing implants and surgical implantation techniques.
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